• Explore /
  • Poster
  • / Phase I study of CC-90010 in patients with advanced solid tumors and relapsed/refractory non-Hodgkin lymphoma (R/R NHL).

Phase I study of CC-90010 in patients with advanced solid tumors and relapsed/refractory non-Hodgkin lymphoma (R/R NHL).

Abstract Poster

Authors

Victor Moreno

Victor Moreno

START Madrid - FJD, Hospital Universitario Fundación Jimenez Diaz, Madrid, Spain

Victor Moreno , Irene Braña , Juan Manuel Manuel Sepulveda Sanchez , Maria Vieito Villar , Tatiana Hernandez-Guerrero , Bernard Doger , Omar Saavedra , Olga Ferrero , Rafael Sarmiento , Marina Arias , Juan De Alvaro , Jorge F. DiMartino , Marlene Zuraek , Tania Sánchez Pérez , Ellen Filvaroff , Ida Aronchik , Manisha Lamba , Bishoy Hanna , Zariana G. Nikolova

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics and Tumor Biology (Nonimmuno)

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

New Targets and New Technologies (non-IO)

Clinical Trial Registration Number

NCT03220347

Citation

J Clin Oncol 37, 2019 (suppl; abstr 3015)

DOI

10.1200/JCO.2019.37.15_suppl.3015

Abstract #

3015

Poster Bd #

7

Abstract Disclosures

Similar Posters

First Author: Ryan C Lynch

First Author: Li Zhang

First Author: J. A. Thompson

First Author: Justin M. Watts